STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

交易中 01-13 11:12:12 EST

77.47

+8.11

+11.69%

最高78.97	最低69.00	成交量90.08万
今开69.18	昨收69.36	日振幅14.37%
总市值53.56亿	流通市值37.98亿	总股本6,914万
成交额6,745万	换手率1.84%	流通股本4,903万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":77.47,"timestamp":1768320730127,"preClose":69.36,"halted":0,"volume":900849,"delay":0,"floatShares":49026700,"shares":69139200,"eps":-3.652895,"marketStatus":"交易中","change":8.11,"latestTime":"01-13 11:12:12 EST","open":69.18,"high":78.97,"low":69,"amount":67454244.367725,"amplitude":0.143743,"askPrice":77.6,"askSize":390,"bidPrice":77.35,"bidSize":13,"shortable":3,"etf":0,"ttmEps":-3.652895,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":69.36,"preHourTrading":{"tag":"盘前","latestPrice":69.59,"preClose":69.36,"latestTime":"09:26 EST","volume":523,"amount":36322.37092,"timestamp":1768314386435},"postHourTrading":{"tag":"盘后","latestPrice":69.36,"preClose":69.36,"latestTime":"19:12 EST","volume":2773,"amount":192294.54,"timestamp":1768263123201},"volumeRatio":3.496272,"impliedVol":0.6671,"impliedVolPercentile":0.1633},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2601812270","title":"硕迪生物盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601812270?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:47","pubTimestamp":1767710851,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时47分，硕迪生物股票出现波动，股价大幅拉升5.13%。截至发稿，该股报65.99美元/股，成交量7.9455万股，换手率0.11%，振幅4.25%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010622473297a12131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010622473297a12131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"1194056049","title":"Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症","url":"https://stock-news.laohu8.com/highlight/detail?id=1194056049","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194056049?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:32","pubTimestamp":1765978346,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"1151839452","title":"Structure Therapeutics宣布成功完成747.5百万美元的增资公开发行ADS及预付认股权证，并全面行使承销商购买附加ADS的选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1151839452","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151839452?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486953,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布成功完成747.5百万美元的增资公开发行ADS及预付认股权证，并全面行使承销商购买附加ADS的选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"1169452002","title":"减肥药概念走强，GPCR涨超5%，诺和诺德涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169452002","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169452002?lang=zh_cn&edition=full","pubTime":"2025-12-10 23:26","pubTimestamp":1765380382,"startTime":"0","endTime":"0","summary":"罗氏控股涨超3%，礼来跟涨。","market":"us","thumbnail":"https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8c3694a08f44a67f8ee972cef2b11b95","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","RHHBY","LLY","GPCR"],"gpt_icon":0},{"id":"1183719988","title":"Structure Therapeutics宣布增强至6.5亿美元的公众发行定价，涉及ADS和预融资认购权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1183719988","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183719988?lang=zh_cn&edition=full","pubTime":"2025-12-10 12:16","pubTimestamp":1765340172,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布增强至6.5亿美元的公众发行定价，涉及ADS和预融资认购权证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2590352124","title":"中概股逆势上涨，硕迪生物涨超110%，比特币突破9.1万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352124","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590352124?lang=zh_cn&edition=full","pubTime":"2025-12-09 00:13","pubTimestamp":1765210437,"startTime":"0","endTime":"0","summary":"北京时间12月8日晚，美股三大指数高开后翻绿，中概股逆势上涨，黄金白银全线飘绿，比特币短线走高升破91000美元。中概股逆势上涨，中国金龙指数涨约0.3%，虎牙涨近8%，大全新能源涨6.4%，百度集团涨超3%。下跌方面，泡泡玛特美股跌约8%。硕迪生物盘前大涨30%，开盘后一路走高，截至发稿涨幅已高达117%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512093585643984.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093585643984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BTC","GPCR","BK4585","BK4594","BK4588","BK4601","83042","BK1611"],"gpt_icon":0},{"id":"1158075123","title":"Structure Therapeutics公布其每日一次口服小分子GLP-1受体激动剂Aleniglipron的积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1158075123","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158075123?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:02","pubTimestamp":1765198975,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公布其每日一次口服小分子GLP-1受体激动剂Aleniglipron的积极顶线数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"1197191118","title":"结构治疗公司第三季度净亏损为6571.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197191118","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197191118?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:00","pubTimestamp":1763571648,"startTime":"0","endTime":"0","summary":"11月6日讯 - 结构治疗公司第三季度经营支出为7378.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"1158433675","title":"异动解读 | 减肥药前景看好，Structure Therapeutics盘中大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158433675","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158433675?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:00","pubTimestamp":1762786833,"startTime":"0","endTime":"0","summary":"周一盘中，Structure Therapeutics股价大涨5.05%，引发市场关注。Structure Therapeutics的实验性口服肥胖症药物在去年的一项中期研究中显示出积极结果。该研究表明，在12周的治疗期内，患者平均减轻了6.2%的体重。随着辉瑞、诺和诺德和礼来等制药巨头纷纷进入这一领域，减肥药市场的竞争日益白热化。Structure Therapeutics作为一家专注于开发口服减肥药的公司，其产品如果成功上市，可能会在这个快速增长的市场中占据重要地位。投资者似乎对公司的前景持乐观态度，推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2579315646","title":"四环医药(00460)与美国AbaloneBio签署合作协议，联合开发新一代减重增肌创新疗法，进一步深化GPCR靶点领域布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315646","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579315646?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:11","pubTimestamp":1761783065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 公布，该集团已与美国生物技术公司AbaloneBio正式签署合作协议。根据协议约定，双方将在全球范围内开展协作，共同推进新一代肥胖治疗创新药物的研发工作。此次合作协议的签署，标志着双方合作从资本层面延伸至业务执行层面，将进一步巩固集团在减重领域的创新布局，并借助Abalone的技术优势，加快新一代减重增肌疗法的研发进度，为集团长期战略发展提供支撑。此外，本次合作亦为集团深化GPCR靶点领域布局的重要举措。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","GPCR","00460","BK4599","BK1515","BK4007","BK1600","BK1191"],"gpt_icon":0},{"id":"2570055022","title":"硕迪生物盘中异动 股价大涨5.16%报25.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570055022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570055022?lang=zh_cn&edition=full","pubTime":"2025-09-25 03:31","pubTimestamp":1758742308,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日03时31分，硕迪生物股票出现异动，股价急速上涨5.16%。截至发稿，该股报25.25美元/股，成交量54.8007万股，换手率0.95%，振幅6.62%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092503314895430861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092503314895430861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2558850641","title":"高盛最新研报以“2Q25 EPS更新”为主题其中重点对Amylyx(AMLX.US)、CG Oncology(CGON.","url":"https://stock-news.laohu8.com/highlight/detail?id=2558850641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558850641?lang=zh_cn&edition=full","pubTime":"2025-08-12 19:17","pubTimestamp":1754997464,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0048573561.USD","LU2471134879.HKD","IE00B19Z3581.USD","LU2237443622.USD","IE0004091025.USD","IE00B19Z3B42.SGD","BK4533","IE0004086264.USD","BK4550","LU1868836914.USD","BK4139","AMLX","BK4504","BK4516","LU0061475181.USD","LU1868837300.USD","LU0096364046.USD","CGON","BK4135","LU2237443549.SGD","BK4599","GPCR","IE00BGHQF748.EUR","159837","CG","IE00B3QW5Z07.USD","LU1894683348.USD","LU1868837136.USD","IE00B64PRP62.GBP","IDYA","LU2471134796.USD","159399","BK4127","IE00BFXG1179.USD","LU2237443465.HKD","LU2750360641.GBP","LU0251131958.USD","LU2237438978.USD","IE00BSNM7G36.USD","LU1868836757.USD","LU2471134952.CNY","LU2750360997.AUD","BK4585","LU2237443895.HKD","LU1868836591.USD","LU2237443978.SGD","LU1668664300.SGD","BK4552","LU0742534661.SGD"],"gpt_icon":0},{"id":"2558603436","title":"硕迪生物盘中异动 临近收盘快速拉升5.00%报17.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558603436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558603436?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:42","pubTimestamp":1754941377,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时42分，硕迪生物股票出现波动，股价快速拉升5.00%。截至发稿，该股报17.13美元/股，成交量71.375万股，换手率1.24%，振幅6.68%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-61.88百万美元，每股收益-1.08美元，毛利-853991.71美元，市盈率-5.43倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812034258a6e0195c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812034258a6e0195c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2557303522","title":"硕迪生物盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303522?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:33","pubTimestamp":1754490793,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时33分，硕迪生物股票出现波动，股价大幅下挫5.10%。截至发稿，该股报15.83美元/股，成交量14.3047万股，换手率0.25%，振幅4.56%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062233139737a226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062233139737a226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2518865271","title":"硕迪生物盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518865271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518865271?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:28","pubTimestamp":1741616909,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时28分，硕迪生物股票出现波动，股价大幅跳水5.11%。截至发稿，该股报21.47美元/股，成交量6.4194万股，换手率0.11%，振幅3.80%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222829a26a3aa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222829a26a3aa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"1148740425","title":"异动解读 | 硕迪生物GPCR股价盘中暴跌6.54%,因公司未有利好消息传出","url":"https://stock-news.laohu8.com/highlight/detail?id=1148740425","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148740425?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:28","pubTimestamp":1741102110,"startTime":"0","endTime":"0","summary":"硕迪生物(GPCR.US)股价今日盘中大跌6.54%,引发市场关注。\n\n从公开消息来看,硕迪生物是一家临床阶段的生物制药公司,主要产品为治疗糖尿病和肥胖症的口服候选药物GSBR-1290。但就目前来看,该公司并未传出任何重大利好消息,导致投资者对公司前景缺乏信心,加之部分资金选择了获利了结,因此可能是造成股价大跌的主要原因。\n\n不过值得注意的是,该股近期财务数据良好,去年全年虽然净亏损达1.23亿美元,但营收有望在新药上市后显著改善。另外机构给予的评级均为买入,显示出对公司长期前景的乐观预期。因此,只要公司研发顺利,未来随着新药问世,股价或将迎来反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 硕迪生物GPCR股价盘中暴跌6.54%,因公司未有利好消息传出","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2516714608","title":"硕迪生物盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516714608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516714608?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:19","pubTimestamp":1741101575,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时19分，硕迪生物股票出现波动，股价快速下挫5.42%。截至发稿，该股报21.13美元/股，成交量10.8238万股，换手率0.19%，振幅4.89%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2516634444","title":"硕迪生物盘中异动 急速跳水5.01%报22.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634444?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:42","pubTimestamp":1741012932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时42分，硕迪生物股票出现波动，股价大幅下挫5.01%。截至发稿，该股报22.56美元/股，成交量5.9494万股，换手率0.10%，振幅4.53%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-9.65倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224212abe636c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224212abe636c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2514202073","title":"硕迪生物盘中异动 早盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514202073?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:41","pubTimestamp":1740753666,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时41分，硕迪生物股票出现异动，股价快速下挫5.30%。截至发稿，该股报21.61美元/股，成交量6.7562万股，换手率0.12%，振幅8.63%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224107a25803e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224107a25803e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2514635433","title":"Structure Therapeutics(GPCR.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.22美元，前值为-0.16美元，预期值为-0.17美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514635433","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514635433?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697726,"startTime":"0","endTime":"0","summary":"Structure Therapeutics(GPCR.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.22美元，前值为-0.16美元，预期值为-0.17美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GPCR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":0.105},{"period":"1month","weight":0.0343},{"period":"3month","weight":1.302},{"period":"6month","weight":2.5388},{"period":"1year","weight":1.7458},{"period":"ytd","weight":-0.0027}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立，在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗各种慢性疾病，满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识，使公司能够开发口服小分子疗法，用于治疗各种疾病，包括影响代谢、心血管和肺系统的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.057508},{"month":2,"riseRate":0,"avgChangeRate":-0.138732},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.094654},{"month":4,"riseRate":0.666667,"avgChangeRate":0.182978},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.022859},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133478},{"month":7,"riseRate":0,"avgChangeRate":-0.101218},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.04351},{"month":9,"riseRate":1,"avgChangeRate":0.463472},{"month":10,"riseRate":0.666667,"avgChangeRate":0.200398},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.123384},{"month":12,"riseRate":0.333333,"avgChangeRate":0.164068}],"exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}